The effectiveness of methotrexate in the treatment of psoriatic arthritis has not been defined. A recent study from SPARCC sheds new light on this important question. Results showed there has been a recent trend towards methotrexate to be used earlier and at higher doses. Dr. Dafna Gladman comments: “This study ahs provided insights into changing practices in the treatment of psoriatic arthritis. More importantly, we have new evidence that methotrexate can lead to better clinical outcomes and can protect against damage to the joints.”
https://sparcc.ca/wp-content/themes/osmosis/images/empty/thumbnail.jpg
150
150
SPARCC
SPARCC
https://sparcc.ca/wp-content/themes/osmosis/images/empty/thumbnail.jpg